Abstract
Genome diversity comprises single nucleotide polymorphisms, deletions, insertions, and duplications. These gains and losses of DNA segments leading to rearrangements of sequences are termed copy number variations (CNVs). CNVs may disrupt genes and/or alter gene dosage and, thereby, have an impact on both protein-coding and noncoding genes. Accordingly, they affect the activity of various signaling pathways and influence the cell phenotype. They are associated with risks for several severe diseases, in particular cancer. In the current chapter, I introduce a rapid profiling method to identify CNVs in circulating, cell-free DNA by multiplex ligation-dependent probe amplification (MLPA). MLPA represents an efficient method for the detection of CNVs among numerous genes on various chromosomal regions in serum.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zarrei M, MacDonald JR, Merico D, Scherer SW (2015) A copy number variation map of the human genome. Nat Rev Genet 16(3):172–183
Bridges CB (1936) The Bar “Gene” a duplication. Science 83(2148):210–211
Mikhail FM (2014) Copy number variations and human genetic disease. Curr Opin Pediatr 26(6):646–652
Barros FF, Powe DG, Ellis IO, Green AR (2010) Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments. Histopathology 56(5):560–572
Liang L, Fang JY, Xu J (2016) Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene 35(12):1475–1482
Walker LC, Wiggins GA, Pearson JF (2015) The role of constitutional copy number variants in breast cancer. Microarrays (Basel) 4(3):407–423
Molparia B, Nichani E, Torkamani A (2017) Assessment of circulating copy number variant detection for cancer screening. PLoS One 12(7):e0180647
Kirkizlar E, Zimmermann B, Constantin T et al (2015) Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology. Transl Oncol 8(5):407–416
Xia S, Huang CC, Le M et al (2015) Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls. Lung Cancer 90(1):78–84
Bettegowda C, Sausen M, Leary RJ et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra224. https://doi.org/10.1126/scitranslmed.3007094
Hehir-Kwa JY, Pfundt R, Veltman JA (2015) Exome sequencing and whole genome sequencing for the detection of copy number variation. Expert Rev Mol Diagn 15(8):1023–1032
Soave A, Chun FK, Hillebrand T et al (2017) Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study. Oncotarget 8(34):56398–56407
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Schwarzenbach, H. (2019). Copy Number Variation Analysis on Cell-Free Serum DNA. In: Casadio, V., Salvi, S. (eds) Cell-free DNA as Diagnostic Markers. Methods in Molecular Biology, vol 1909. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8973-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8973-7_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8972-0
Online ISBN: 978-1-4939-8973-7
eBook Packages: Springer Protocols